Author: Olivia Dimmer
-
‘Leaky’ Muscle Fibers Drive Immune Response in Muscular Dystrophy
A Northwestern Medicine study has uncovered how chronic defects in muscle membrane repair can fuel harmful inflammation, according to the study published in JCI Insight.
-
Immunotherapy Shows Long-Term Promise in Aggressive Lymphoma
A leading-edge immunotherapy may extend survival for patients with one of the most aggressive forms of blood cancer, according to newly published five-year results from a major clinical trial in the journal Blood.
-
Signaling Pathway May Help Predict Immunotherapy Response in Glioblastoma
Northwestern Medicine scientists have uncovered a biological mechanism that helps explain why most patients with glioblastoma fail to respond to immunotherapy, according to a study published in Nature Communications.
-
New Analytic Method Reveals ‘Building Blocks’ of Brain Activity
A new Northwestern Medicine study has introduced a novel machine learning method for understanding how the brain organizes complex behaviors, offering fresh evidence that neural activity is built from reusable “building blocks,” according to the study published in Neuron.
-
Intricate Molecular Mechanisms Help Bacteria Evade Immune Detection
Northwestern scientists have identified a novel mechanism utilized by the bacteria responsible for gonorrhea to evade immune detection and achieve widespread infection, according to a recent study published in the Proceedings of the National Academy of Sciences.
-
Blood Cell ‘Nurseries’ Upend Understanding of Human Physiology
Northwestern Medicine scientists have discovered that one of the body’s most fundamental biological processes — how red blood cells are made — works differently in humans than previously thought, according to a new study published in Nature Genetics.
-
Immunotherapy Strategy Shows Promise for Deadly Brain Cancer
A new immunotherapy strategy has shown promise in targeting one of the most aggressive and deadly forms of brain cancer, according to a new study published in Nature.
-
Combination Therapy Shows Promise in High-Risk Prostate Cancer, Study Finds
A large international clinical trial has found that adding the drug apalutamide to standard hormone therapy before and after prostate cancer surgery significantly improves outcomes for men with high-risk disease, according to details published in The New England Journal of Medicine.
-
Understudied Enzyme Helps Pathogen Prosper, Study Finds
A new study published in the Proceedings of the National Academy of Sciences has offered insight into how Staphylococcus aureus, a major human pathogen, fine-tunes its internal RNA degradation machinery to survive stress and potentially cause infection.
-
Identifying Immune Pathways Driving Aggressive Brain Cancers
A new study has uncovered a key mechanism that helps one of the deadliest brain cancers evade the immune system, according to the study published in The Journal of Clinical Investigation.
